FOS and prostate cancer: The anti-invasion and antimetastasis of ISL on the DU145 prostate cancer cell line have been investigated, with the findings suggesting that this mechanism could be achieved through the inhibition of JNK/AP-1 signaling and the downregulation of the reduction of μPA, MPP-9, and AP-1.